tiprankstipranks
Biotest (0N6Z) (DE:BIO)
:BIO
Germany Market

Biotest (BIO) Income Statement

Compare
3 Followers

Biotest Income Statement

Last quarter (Q3 2024), Biotest's total revenue was €150.70M, a decrease of -40.39% from the same quarter last year. In Q3, Biotest's net income was €-9.30M. See Biotest’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 684.60M€ 516.10M€ 515.60M€ 484.20M€ 419.10M
Gross Profit
€ 280.30M€ 124.90M€ 80.70M€ 130.10M€ 128.80M
Operating Expenses
€ 136.80M€ 133.40M€ 132.80M€ 132.60M€ 135.50M
Depreciation and Amortization
€ 35.90M€ 35.70M€ 31.10M€ 29.60M€ 31.70M
EBITDA
€ 179.00M€ 28.30M€ -17.70M€ 16.00M€ 39.40M
Operating Income
€ 143.50M€ -13.00M€ -52.10M€ -13.20M€ -6.50M
Other Income/Expenses
€ -37.20M€ -17.80M€ -16.80M€ -16.80M€ -100.00K
Pretax Income
€ 106.30M€ -30.80M€ -62.60M€ -30.00M€ -1.30M
Net Income
€ 127.00M€ -31.60M€ -63.30M€ -31.40M€ -4.70M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 3.21€ -0.80€ -1.60€ -0.79€ -0.12
Diluted EPS
€ 3.21€ -0.80€ -1.60€ -0.79€ -0.12
Weighted Average Shares Outstanding
39.57M 39.57M 39.57M 39.57M 39.57M
Weighted Average Shares Outstanding (Diluted)
39.57M 39.57M 39.57M 39.57M 39.57M
Currency in EUR

Biotest Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis